When was HighLife Medical founded?

HighLife Medical was founded in 2010 and raised its 1st funding round 7 years after it was founded.

Where is HighLife Medical located?

HighLife Medical is headquartered in Paris, France.

How many employees does HighLife Medical have?

As of Aug 31, 2026, the latest employee count at HighLife Medical is 97.

Is HighLife Medical a funded company?

HighLife Medical is a funded company, having raised a total of $141M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 30, 2017.

When was the latest funding round of HighLife Medical?

HighLife Medical's latest funding was a $***** Series C round on Sep 22, 2026, with participation from 13 investors.

Where does HighLife Medical rank among its competitors?

HighLife Medical ranks 9th amongst 114 active competitors, of which 51 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was CroiValve, which secured $20M in Jun, 2026.

HighLife Medical - 2026 Company Profile, Team, Funding & Competitors

Q: Who are the top competitors of HighLife Medical?

HighLife Medical's top competitors include Shockwave Medical, MicroPort CardioFlow Medtech Corporation and Peijia Medical Technologies. Among them, HighLife Medical secured the most recent funding round in September, 2026.

HighLife Medical is a series C company based in Paris (France), founded in 2010 by George Bortlein and Malek Nasr. It operates as a Developer of trans-catheter mitral valve replacement system. HighLife Medical has raised $141M in funding from investors like USVP, VI Partners and Sofinnova Partners. The company has 114 active competitors, including 51 funded and 29 that have exited. Its top competitors include companies like Shockwave Medical, MicroPort CardioFlow Medtech Corporation and Peijia Medical Technologies.

Company Details

HighLife Medical is developing a transcatheter mitral valve replacement system for the treatment of patients suffering from mitral valve regurgitation. It consists of two components, a valve prosthesis, and a ring-shaped sub-annular implant (SAI). The valve self-centers and aligns itself upon delivery inside the SAI ring surrounding it.

Website: www.highlifemedical.com/
Social

Key Metrics

Founded Year

2010

Location

Paris, France

Stage

Series C

Total Funding

$141M in 4 rounds

Latest Funding Round

Series C, Sep 22, 2026, $*****

Investors

USVP & 8 more

Ranked

9^th among 114 active competitors

Employee Count

97 as on Aug 31, 2026

Similar Companies

Shockwave Medical & 147 more

View HighLife Medical's full profile

HighLife Medical has raised a total funding of $141M over 4 rounds. Its first funding round was on Oct 30, 2017. Its latest funding round was a Series C round on Sep 22, 2026 for $*****. 13 investors participated in its latest round. HighLife Medical has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of HighLife Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 22, 2026	7913799	Series C	7448002	2157943	2794436	8829445
Dec 11, 2020	7638650	Series B	9432113	5668078	5379711	7836624
Jan 17, 2019	6603038	Series B	3425098	9909236	USVP & 1 more	Sectoral & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of HighLife Medical's funding rounds and investors

The founders of HighLife Medical are George Bortlein and Malek Nasr.

Here are the details of HighLife Medical's key team members:

George Bortlein: Founder of HighLife Medical.
Malek Nasr: Co-Founder of HighLife Medical.

View details of HighLife Medical's Founder profiles and Board Members

HighLife Medical's employee count trend

HighLife Medical has 97 employees as of Aug 26. Here is HighLife Medical's employee count trend over the years:

Employee count trend for HighLife Medical

Uncover HighLife Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of HighLife Medical include Shockwave Medical, MicroPort CardioFlow Medtech Corporation and Peijia Medical Technologies. Here is the list of Top 10 competitors of HighLife Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Shockwave Medical 2009, Santa Clara (United States), Acquired	Developer of cardiovascular balloon dilation catheters	$148M	Sofinnova Partners, Venrock & 9 others	65/100
2nd	MicroPort CardioFlow Medtech Corporation 2015, Pudong (China), Public	Developer of smart medical devices for patients with heart valve diseases	$132M	Lake Bleu Capital, CICC & 10 others	63/100
3rd	Peijia Medical Technologies 2012, Suzhou (China), Public	Developer of medical devices for the treatment of cardiac and cerebrovascular diseases	$110M	Lilly Asia Ventures, SDIC Innovation & 9 others	63/100
4th	Cardiac Dimensions 2001, Kirkland (United States), Series E	Developer of invasive cardiac implants for heart failure	$261M	Life Sciences Partners, Lumira Ventures & 20 others	62/100
5th	JenaValve Technology 2006, Irvine (United States), Acquired	Provider of pericardial transcatheter aortic valve replacement and delivery system	$364M	Sunstone, Valiance Asset Management & 19 others	62/100
6th	Venus MedTech 2009, Hangzhou (China), Public	Transcatheter aortic valves	$37M	DCP, HongShan & 6 others	62/100
7th	CroiValve 2016, Dublin (Ireland), Series B	Developer of a percutaneous device for treating tricuspid regurgitation	$52.1M	Irrus Investments, Halo Business Angel Network ... & 21 others	58/100
8th	TRiCares 2013, Aschheim (Germany), Series D	Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on developing a safe and effective solution to address the limitations of existing treatment approaches. It is developing a catheter-based system for tricuspid valve replacement. The company's efforts include clinical trials and securing funding to support further development and clinical milestones.	$103M	415 CAPITAL, Lifeblood Capital & 10 others	58/100
9th	HighLife Medical 2010, Paris (France), Series C	Developer of trans-catheter mitral valve replacement system	$141M	Sectoral, LivaNova & 7 others	57/100
10th	Innovheart 2015, Milano (Italy), Series C	Provider of aesthetic devices for the treatment of atrioventricular valve diseases	$78.7M	Panakes Partners, Genextra & 5 others	56/100